Archive page of posts in this category or categories:

The following posts are in no particular order. They are purposely randomized.

Client Needs

Risk on Retainer

In a fast-moving risk environment, waiting to engage external expertise can cost valuable time and clarity. Organizations benefit from having pre-established access to risk specialists who already understand their operations, priorities, and constraints. When trusted advisors are standing by—briefed and ready—response times shrink, decision quality improves, and organizational resilience increases.
Read More
Experts

Ian Arnold

As an Associate Expert with Risk Sciences International, Dr. Arnold brings clinical depth and field experience to RSI’s work in occupational health risk assessment and workplace safety policy development. He provides expert insight on topics such as exposure-related health outcomes, physical and psychological stressors in industrial settings, and the integration of clinical data into population-level risk models.
Read More
Experts

Rosanna Wong

Rosanna Wong is a Junior Risk Analyst at Risk Sciences International (RSI), where she supports multidisciplinary projects at the intersection of climate resilience, food systems, and public safety. Since joining RSI in 2021, Rosanna has contributed to a broad range of research areas, including foodborne disease, intentional food adulteration, transportation and natural disaster risks, and climate change adaptation strategies.
Read More
Experts

Anne Wiles

Dr. Anne Wiles joined Risk Sciences International (RSI) in 2008, where she currently serves as a Senior Analyst specializing in risk communication, perception, and governance. With a distinctive blend of expertise in language, regulation, and the use of science in decision-making, Anne has contributed to a wide range of RSI projects focused on the human and institutional dimensions of risk. Her work includes developing health risk communication strategies and drafting publicly accessible scientific information, advising on public messaging for nuclear energy and nuclear waste management, and supporting regulatory agencies in the evaluation and management of complex risk portfolios. She has been deeply involved in several RSI projects examining how mandates, institutional contexts, and public attitudes shape regulatory decision-making across federal domains. Anne has also contributed to scholarly work at RSI, including co-authoring a scoping review on the evolution of health and environmental risk decision-making, an article on the potential health risks associated with aluminum, and a book chapter on public concerns related to blood safety. In addition to her project work, Anne is a university instructor, teaching two courses: a broad overview of societal approaches to risk, and a graduate seminar on risk management in government, where she integrates academic theory with real-world regulatory case studies and risk communication practice.
Read More
Client Needs

Public and Workplace Safety

Preventable harm in workplaces or public spaces can trigger regulatory enforcement, reputational loss, service disruption, or long-term loss of public trust. These harms may stem from failures in equipment, processes, human behavior, or oversight—and are often foreseeable through systematic risk assessment. For organizations responsible for public environments, infrastructure, or service delivery, risk-based safety planning offers a path to pre-empt injury, legal exposure, and crisis escalation.
Read More
xp

HV Attendee Dashboard

If you have already registered for the HV Consensus Conference, you may log-in using the link below to access the HV Attendee Dashboard:

Log in to the Attendee Dashboard

 

Otherwise, please visit the Canadian Recipient Hemovigilance System Renewal Process homepage for more information:

To the HV Homepage

Note that this is a password protected page.

 

Read More
RSI News

Dr. Mattison chairs NAM report

Compounded medications prepared by pharmacists or physicians have been used extensively throughout history as a mainstay of therapeutics.  Over the past half-century – with the increasing focus on evidence based treatment the use of compounded medications substantially decreased.  However, in some therapeutic areas, such as menopause, use of compounded medications continues.  The continuation of use…
Read More
Experts

Paul Price

Dr. Paul Price is a Senior Analyst at Risk Sciences International (RSI), bringing over four decades of experience as a pioneer in exposure science and chemical risk assessment. Since joining RSI in 2019, Dr. Price has focused on advancing mixture risk assessment—an increasingly vital area as regulators shift from assessing single chemicals in isolation to understanding the cumulative effects of combined exposures. His current work includes the development of Mixture Adjustment Factors, participation in international regulatory committees, and authorship of scholarly publications aimed at refining the science-policy interface of chemical mixture risk.
Read More
Methods

Structured expert judgment

RSI applies structured expert judgment methods in areas such as toxicology, disaster risk, and emerging technology assessment. The firm manages expert panels, designs elicitation instruments, and synthesizes results into risk estimates or scenario inputs. RSI ensures transparency and defensibility through documented methods and peer-reviewed protocols.
Read More
RSI News

Principles of risk decision-making

RSI investigators propose fundamental principles of risk decision-making, and explore their application in a range of real-world risk decision-making contexts. These ten principles will provide valuable guidance on addressing current and future risk issues facing civil societies worldwide.
Read More